
Vælg din etiket
vises direkte på hætteglassetACE-031
Muscle Building
- Sendes fra Tyskland
Bestilling
- DHL med sporing
- Diskret emballage
Kort fortalt
ACE-031 i tal
Nøgletallene fra vores leksikon.
Hele leksikonopslaget- Class
- ActRIIB-Fcmyostatin/activin trap
- Half-life
- longfusion protein
- Use
- Subcutaneousno established protocol
- Sizes
- 1 mg1 size in the shop
What studies show
All 2 sources in the lexicon- Attie et al., Muscle & Nerve, 2013
ACE-031 in boys with Duchenne muscular dystrophy (study stopped early) (opens in a new tab)
Campbell et al., Muscle & Nerve, 2017
Der er endnu ingen laboratorieanalyse for ACE-031. Stem på denFå det testet selv, vi betaler halvdelenAlle laboratorieanalyser
Viden
Alt om ACE-031
Detaljerede oplysninger kommer snart.
Godt at have
Det har du brug for til den
Bakteriostatisk vand lægges automatisk i din kurv. Sprøjter og servietter med ét klik.
Insulinsprøjter
10 stk. · 5.50 €
Spritservietter
50 stk. · 10 €
Hvor meget vand?
Enheder på sprøjten til din hætteglasstørrelse.
Åbn beregneren →What is ACE-031?
A large fusion protein: the outer part of the activin receptor IIB, linked to a piece of an antibody (IgG1 Fc). It binds myostatin and related messengers in the blood before they reach the receptor on muscle. The compound name is ramatercept.
What did the first human study show?
48 healthy postmenopausal women received a single dose at ascending levels or placebo. In the group with the highest study dose lean mass rose by 3.3 percent and thigh muscle volume by 5.1 percent after 29 days. The half-life was 10 to 15 days.
Why was development stopped?
In the trial in boys with Duchenne muscular dystrophy nosebleeds and telangiectasias occurred, meaning widened small blood vessels. The trial was stopped after the second dosing regimen because of potential safety concerns. The activin receptor IIB acts not only on muscle but also on vessels.
Was there a benefit in Duchenne?
Only trends. The 6-minute walk distance tended to be maintained in the ACE-031 groups while it declined on placebo. There were also trends towards more lean mass and bone density and less fat mass. None of this was statistically significant.
Is ACE-031 approved?
No. ChEMBL lists ramatercept with phase 2 as the highest phase. ClinicalTrials.gov lists four trials from 2008 to 2011, both phase 2 trials were terminated early (as of 26 October 2026).
What do animal studies show?
In marmosets lean mass increased over 14 weeks on ACE-031, muscle fibres became thicker and muscle force rose. This did not happen in the control group. The authors see this as a pointer for muscle diseases in humans.
Relateret
Relaterede produkter
IGF-1 LR3
Peptider · Vækst & muskler Vækst & muskler
2 størrelser
= fra 11.6 €/hætteglas
MGF
Peptider · Vækst & muskler Vækst & muskler
1 størrelse
= 13.2 €/hætteglas
PEG-MGF
Peptider · Vækst & muskler Vækst & muskler
1 størrelse
= 22 €/hætteglas
FST-344 (Follistatin)
Peptider · Vækst & muskler Vækst & muskler
1 størrelse
= 53.2 €/hætteglas
ACE-031